Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's alleged release of confidential Visx data to Summit probed by Rep. Barton and agency.

This article was originally published in The Gray Sheet

Executive Summary

ALLEGED FDA RELEASE OF VISX CONFIDENTIAL LASER DATA TO SUMMIT is being probed on Capitol Hill as well as internally at FDA. House Commerce/Oversight Subcommittee Chairman Joe Barton (R-Tex.) has been monitoring allegations that FDA sent confidential documents on Visx' recently approved excimer laser for photorefractive keratectomy to Summit Technology, Visx' primary competitor. The subcommittee chairman may initiate a more formal investigation in the next few weeks.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel